0001615898-18-000001.txt : 20180112 0001615898-18-000001.hdr.sgml : 20180112 20180112095719 ACCESSION NUMBER: 0001615898-18-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180112 DATE AS OF CHANGE: 20180112 EFFECTIVENESS DATE: 20180112 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Pear Therapeutics, Inc. CENTRAL INDEX KEY: 0001615898 IRS NUMBER: 463597074 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-303091 FILM NUMBER: 18524912 BUSINESS ADDRESS: STREET 1: 55 TEMPLE PL., 3RD FLOOR CITY: BOSTON STATE: MA ZIP: 02111 BUSINESS PHONE: 6469322774 MAIL ADDRESS: STREET 1: 55 TEMPLE PL., 3RD FLOOR CITY: BOSTON STATE: MA ZIP: 02111 D 1 primary_doc.xml X0708 D LIVE 0001615898 Pear Therapeutics, Inc. 745 Atlantic Avenue BOSTON MA MASSACHUSETTS 02111 6174437327 DELAWARE None None Corporation true 2013 Corey McCann c/o Pear Therapeutics 745 Atlantic Avenue Boston MA MASSACHUSETTS 02111 Executive Officer Director Andrew Schwab c/o Pear Therapeutics 745 Atlantic Avenue Boston MA MASSACHUSETTS 02111 Director Zack Lynch c/o Pear Therapeutics 745 Atlantic Avenue Boston MA MASSACHUSETTS 02111 Director Timothy Petersen c/o Pear Therapeutics 745 Atlantic Avenue Boston MA MASSACHUSETTS 02111 Director Christopher Guiffre c/o Pear Therapeutics 745 Atlantic Avenue Boston MA MASSACHUSETTS 02111 Executive Officer Antoun Nabhan c/o Pear Therapeutics 745 Atlantic Avenue Boston MA MASSACHUSETTS 02111 Executive Officer Other Health Care Decline to Disclose 06b false 2017-12-28 false true false 0 50999997 45999998 4999999 $4,999,999 reserved for sale at a second closing of the offering. false 14 0 0 0 false Pear Therapeutics, Inc. /s/ Corey McCann Corey McCann President and CEO 2018-01-11